Literature DB >> 18704660

The relevance of mouse models to understanding the development and progression of human breast cancer.

D Craig Allred1, Daniel Medina.   

Abstract

Mouse modeling of human breast cancer has developed tremendously over the past ten years. Human breast cancer is characterized by enormous biological diversity and, collectively, the new models have come much closer to encompassing this diversity. They have provided a deeper understanding of the fundamental events that mediate the initiation, development, and progression of breast cancer, and they offer new opportunities to develop and test strategies to treat and, perhaps, even prevent the disease. This chapter reviews the historical development of mouse models of breast cancer and highlights some of their major strengths, weaknesses, and contributions.

Entities:  

Mesh:

Year:  2008        PMID: 18704660     DOI: 10.1007/s10911-008-9093-5

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  90 in total

1.  Three-dimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression.

Authors:  Celeste M Nelson; Jamie L Inman; Mina J Bissell
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.

Authors:  H Y Shi; W Zhang; R Liang; S Abraham; F S Kittrell; D Medina; M Zhang
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

3.  Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.

Authors:  S Ménard; P Aiello; E Tagliabue; C Rumio; P L Lollini; M I Colnaghi; A Balsari
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

4.  Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.

Authors:  Kendall Wu; Hee-Tae Kim; Jenny L Rodriquez; Susan G Hilsenbeck; Syed K Mohsin; Xiao-Chun Xu; William W Lamph; John G Kuhn; Jeff E Green; Powel H Brown
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-05       Impact factor: 4.254

5.  Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.

Authors:  Gargi D Basu; Latha B Pathangey; Teresa L Tinder; Michelle Lagioia; Sandra J Gendler; Pinku Mukherjee
Journal:  Mol Cancer Res       Date:  2004-11       Impact factor: 5.852

Review 6.  Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Authors:  Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-29       Impact factor: 2.673

Review 7.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

8.  Hormone-induced chromosomal instability in p53-null mammary epithelium.

Authors:  Debananda Pati; Bassem R Haddad; Albert Haegele; Henry Thompson; Frances S Kittrell; Anne Shepard; Cristina Montagna; Nenggang Zhang; Gouqing Ge; Subhendu Kumar Otta; Maureen McCarthy; Robert L Ullrich; Daniel Medina
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

9.  Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

Authors:  Chunhua Lu; Corey Speers; Yun Zhang; Xiaochun Xu; Jamal Hill; Emily Steinbis; Joseph Celestino; Qiang Shen; Heetae Kim; Susan Hilsenbeck; Syed K Mohsin; Alan Wakeling; C Kent Osborne; Powel H Brown
Journal:  J Natl Cancer Inst       Date:  2003-12-17       Impact factor: 13.506

10.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  20 in total

1.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

2.  BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer.

Authors:  Philip H Jones; Wadie D Mahauad-Fernandez; Marisa N Madison; Chioma M Okeoma
Journal:  Virology       Date:  2013-06-25       Impact factor: 3.616

Review 3.  Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Authors:  Rebecca B Riggins; Mary M Mazzotta; Omar Z Maniya; Robert Clarke
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 4.  Pregnancy-induced changes in breast cancer risk.

Authors:  Irma H Russo; Jose Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09       Impact factor: 2.673

5.  Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Authors:  Anne M Miermont; Angela R Parrish; Priscilla A Furth
Journal:  Carcinogenesis       Date:  2010-02-24       Impact factor: 4.944

6.  Screening and analysis of breast cancer genes regulated by the human mammary microenvironment in a humanized mouse model.

Authors:  Mingjie Zheng; Jue Wang; Lijun Ling; Dandan Xue; Shui Wang; Yi Zhao
Journal:  Oncol Lett       Date:  2016-10-24       Impact factor: 2.967

7.  Progesterone receptor action: defining a role in breast cancer.

Authors:  Andrea R Daniel; Christy R Hagan; Carol A Lange
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05-01

8.  Pituitary tumor transforming gene binding factor: a new gene in breast cancer.

Authors:  Rachel J Watkins; Martin L Read; Vicki E Smith; Neil Sharma; Gary M Reynolds; Laura Buckley; Craig Doig; Moray J Campbell; Greg Lewy; Margaret C Eggo; Laurence S Loubiere; Jayne A Franklyn; Kristien Boelaert; Christopher J McCabe
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

9.  Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.

Authors:  Giovanni P Burrai; Sulma I Mohammed; Margaret A Miller; Vincenzo Marras; Salvatore Pirino; Maria F Addis; Sergio Uzzau; Elisabetta Antuofermo
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

10.  Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.

Authors:  Maria Laura Polo; Maria Victoria Arnoni; Marina Riggio; Victoria Wargon; Claudia Lanari; Virginia Novaro
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.